|
Hamburg Calls on International Counterparts to Be Transparent
PHILADELPHIA — The FDA and international regulators must establish a much more collaborative framework in order to ensure the safety of the world’s drug supply chains, FDA Commissioner Margaret Hamburg says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives